Statement Of Cash Flows [Abstract]

Fresenius Medical Care AG & Co. KGaA - Filing #6524128

Concept 2023-01-01 to
2023-12-31
2022-01-01 to
2022-12-31
2021-01-01 to
2021-12-31
Statement of cash flows [abstract]
Cash flows from (used in) operating activities [abstract]
Adjustments for finance income (cost)
336,423 EUR
292,476 EUR
280,429 EUR
Adjustments for deferred tax expense
122,149 EUR
41,471 EUR
67,259 EUR
Adjustments for decrease (increase) in other assets
145,697 EUR
154,031 EUR
164,201 EUR
Adjustments for depreciation and amortisation expense and impairment loss (reversal of impairment loss) recognised in profit or loss
1.751.971 EUR
1.838.363 EUR
1.623.676 EUR
Adjustments for undistributed profits of investments accounted for using equity method
121,785 EUR
66,559 EUR
92,175 EUR
Cash flows from (used in) financing activities [abstract]
Dividends paid to equity holders of parent, classified as financing activities
328,623 EUR
395,556 EUR
392,455 EUR
Proceeds from exercise of options
EUR
20,153 EUR
6,511 EUR
Proceeds from non-current borrowings
417,877 EUR
986,922 EUR
1.244.094 EUR
Repayments of non-current borrowings
700,663 EUR
744,620 EUR
2.083.000 EUR
Proceeds from contributions of non-controlling interests
42,615 EUR
88,505 EUR
55,309 EUR

Talk to a Data Expert

Have a question? We'll get back to you promptly.